Bioventus Inc. 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001665988-26-000011
- Form type
- 10-K
- CIK
- 0001665988
- Primary document
- https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/bvs-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bioventus Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $568.1M | - | - |
| Cost Of Revenue | $179.9M | - | - |
| Gross Profit | $388.2M | - | - |
| Operating Income | $54.0M | - | - |
| Net Income | $22.7M | - | - |
| Eps Basic | 0.34 | - | - |
| Eps Diluted | 0.33 | - | - |
| Cash And Equivalents | $51.2M | - | - |
| Total Assets | $683.6M | - | - |
| Total Liabilities | $455.1M | - | - |
| Shareholders Equity | $184.1M | - | - |
| Operating Cash Flow | $74.7M | - | - |
| Capital Expenditures | $2.6M | - | - |